A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Hoffmann-La Roche
Hoffmann-La Roche
University of Utah
University Hospital, Basel, Switzerland
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
UNC Lineberger Comprehensive Cancer Center
University of Alabama at Birmingham
Ann & Robert H Lurie Children's Hospital of Chicago
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
University Hospital, Montpellier
BioAegis Therapeutics Inc.